Previous 10 | Next 10 |
2023-09-13 12:01:30 ET Summary Hyperfine aims to make MRI scans more accessible with its low-energy MRI scanner called the Swoop. The Swoop offers several advantages over conventional MRI scanners, including lower cost, ease of use, and reduced safety concerns. The company has...
2023-08-17 17:37:41 ET Gainers: EDAP ( NASDAQ: EDAP ) +7% . Hyperfine ( HYPR ) +7% . Ross Stores ( ROST ) +6% . Verint Systems ( VRNT ) +6% . NanoString Technologies ( NSTG ) +4% . Losers: VinFast Auto ...
2023-08-14 20:34:09 ET Hyperfine Inc. (HYPR) Q2 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Marissa Bych - IR Maria Sainz - CEO, President & Director Brett Hale - Chief Administrative Officer and CFO Conference Call Part...
2023-08-14 16:32:44 ET Hyperfine press release ( NASDAQ: HYPR ): Q2 GAAP EPS of -$0.15 beats by $0.02 . Revenue of $3.38M (+120.9% Y/Y) beats by $0.58M . For further details see: Hyperfine GAAP EPS of -$0.15 beats by $0.02, revenue of $3.38M beats by $0.58M
GUILFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced second quarter 2023 financial results and provided a ...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the second quarter 2023 on Monday, August 14, 2023. Management will h...
2023-07-19 10:22:17 ET Gainers: Panbela Therapeutics ( PBLA ) +36% . 60 Degrees Pharmaceuticals ( SXTP ) +20% . CareMax ( CMAX ) +20% . Biodexa Pharmaceuticals ( BDRX ) +13% . bluebird bio ( BLUE ) +13% . Losers: Amar...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, today announced the promotion of Tom Teisseyre, Ph.D. to chief operating officer. Dr. Teisseyr...
2023-07-18 10:13:56 ET Gainers: iCAD ( ICAD ) +31% . Biophytis ( BPTS ) +27% . Hyperfine ( HYPR ) +15% . Cabaletta Bio ( VERU ) +12% . Mind Medicine (MindMed) ( MNMD ) +10% . Losers: Lixte Biotechnology ( LIXT ) ...
In addition to the study, the company appoints a world-class stroke advisory board as part of its acute ischemic stroke initiatives Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared po...
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...